Horizon Europe-funded HERMOD project launches to support Phase 2 development of HER-096 in Parkinson’s disease
GlobeNewswire, Inc.
Espoo, Finland, 11 November 2026: Herantis Pharma Plc (“Herantis”), a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson’s disease, today announces that the Horizon Europe-funded research Project...
Conductor and Educator Dr. Jason Noble Returns 'Home' to Columbia as 'The Patient as Professor'
EIN Presswire
Noble shares his experience with metastatic thyroid cancer and a rare endocrine disorder with Columbia medical and dental students on Nov. 30 NEW YORK, NY, UNITED STATES, November 20, 2026 /EINPresswire.com/ -- Dr. Jason Noble, associate...
Herantis Pharma: newly published clinical evidence validates HER-096 Phase 2 study design
GlobeNewswire, Inc.
Phase 2 study will assess HER-096’s efficacy in approximately 100 participants, using a smartphone-based motor assessment as the primary efficacy endpoint, including nine months of placebo-controlled treatment followed by six months of HER-096...
UPDATE -- Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study
GlobeNewswire, Inc.
FREMONT, Calif. and HELSINKI, Finland, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR) and Nightingale Health Plc (Nasdaq Helsinki: HEALTH, OTCQX: NHLTY, NGHLF) today announced the launch of the UK Biobank vanguard study...
Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study
GlobeNewswire, Inc.
FREMONT, Calif. and HELSINKI, Finland, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR) and Nightingale Health Plc (Nasdaq Helsinki: HEALTH, OTCQX: NHLTY, NGHLF) today announced the launch of the UK Biobank vanguard study...
Cardiolyse Launches AI-Powered ECG Workspace for 12-Lead ECG Review from First Read to Clinician Sign-Off
GlobeNewswire, Inc.
Cardiolyse Launches AI-Powered ECG Workspace for 12-Lead ECG Review from First Read to Clinician Sign-Off Rebuilt platform combines AI-powered 12-lead ECG analysis, editable findings, and clinician sign-off in one browser tab. HELSINKI, Finland,...
Video Stories
Sign up for:
Health Daily Finland
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.